Paying for Oral Targeted Therapies -  Targ Ther 2019

Paying for Oral Targeted Therapies - Targ Ther 2019

cancergrace

4 weeks
24 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Challenges and Pathways to Coverage, with Christine Cambareri, PharmD, BCPS, BCOP. For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
Up Next Autoplay
Personalized Algorithms: How is this different?
Personalized Algorithms: How is this different?
Category: Immunotherapy
2 Views
Cancer-News 19 hours
Algorithm Personalizing Best Targets for Immunotherapy
Algorithm Personalizing Best Targets for Immunotherapy
Category: Immunotherapy
2 Views
Cancer-News 20 hours
Algorithm personalizes the best targets for immunotherapy for cancer mutations.
Algorithm personalizes the best targets for immunotherapy for cancer mutations.
Category: Immunotherapy
5 Views
Cancer-News 20 hours
Analysis of Patients with Prior Gastrectomy Treated with LONSURF® (trifluridine and tipiracil) Published in JAMA Oncology
Analysis of Patients with Prior Gastrectomy Treated with LONSURF® (trifluridine and tipiracil) Published in JAMA Oncology
Category: Pancreatic Cancer
3 Views
Cancer-News 21 hours
Phase 2 PLEIADES Study: How This Affects Clinicians?
Phase 2 PLEIADES Study: How This Affects Clinicians?
Category: Multiple Myeloma
0 Views
Mount Sinai Health System 23 hours
PLEIADES Study: How Long Are Patients in Clinic?
PLEIADES Study: How Long Are Patients in Clinic?
Category: Multiple Myeloma
0 Views
Mount Sinai Health System 23 hours
Phase 2 PLEIADES Study
Phase 2 PLEIADES Study
Category: Multiple Myeloma
0 Views
Mount Sinai Health System 23 hours
BEACON Trial: What's Next?
BEACON Trial: What's Next?
Category: Colorectal Cancer
2 Views
Cancer-News 1 day
Phase 3 BEACON CRC Trial
Phase 3 BEACON CRC Trial
Category: Colorectal Cancer
17 Views
Cancer-News 1 day
EV-103: Enfortumab Vedotin plus Pembrolizumab #ESMO19
EV-103: Enfortumab Vedotin plus Pembrolizumab #ESMO19
Category: Bladder Cancer
9 Views
Cancer-News 1 day